Krajina: Spojené štáty
Jazyk: angličtina
Zdroj: NLM (National Library of Medicine)
TECHNETIUM TC-99M SESTAMIBI (UNII: 971Z4W1S09) (TECHNETIUM TC-99M SESTAMIBI - UNII:971Z4W1S09)
Jubilant HollisterStier General Partnership
TECHNETIUM TC-99M SESTAMIBI
TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE 1 mg in 10 mL
PRESCRIPTION DRUG
APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT
TECHNETIUM TC 99M SESTAMIBI- TECHNETIUM TC 99M SESTAMIBI INJECTION JUBILANT HOLLISTERSTIER GENERAL PARTNERSHIP ---------- SES TAMIBI PRINCIPAL DISPLAY PANEL SESTAMIBI 10 COUNT TECHNETIUM TC 99M SESTAMIBI technetium tc 99m sestamibi injection PRODUCT INFORMATION Jubilant HollisterStier General Partnership PRODUCT T YPE HUMAN PRESCRIPTION DRUG ITE M CODE (SOURCE ) NDC:76 112-141 ROUTE OF ADMINISTRATION INTRAVENOUS ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH TECHNETIUM TC-9 9 M SESTAMIBI (UNII: 9 71Z4W1S0 9 ) (TECHNETIUM TC-9 9 M SESTAMIBI - UNII:9 71Z4W1S0 9 ) TETRAKIS(2- METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE 1 mg in 10 mL INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH TRISO DIUM CITRATE DIHYDRATE (UNII: B22547B9 5K) 2.6 mg in 10 mL CYSTEINE HYDRO CHLO RIDE (UNII: ZT9 34N0 X4W) 1 mg in 10 mL MANNITO L (UNII: 3OWL53L36 A) 20 mg in 10 mL STANNO US CHLO RIDE (UNII: 1BQV3749 L5) 0 .0 75 mg in 10 mL PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:76 112-141-10 10 in 1 KIT 0 7/0 1/20 0 9 1 10 mL in 1 VIAL; Type 0 : No t a Co mbinatio n Pro duct MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT ANDA0 78 8 0 6 0 7/0 1/20 0 9 LABELER - Jubilant HollisterStier General Partnership (246762764) Revised: 11/2017 Prečítajte si celý dokument